Trial Profile
Phase II clinical study with expanded study population and to further evaluate the clinical safety, immunogenicity and efficacy of the Hepatitis B Vaccine with PIKA Adjuvant.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 13 Apr 2023
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacodynamics
- 14 Mar 2023 According to a YS Biopharma media release, the Yisheng Biopharma merged with Summit Healthcare Acquisition Corp and the combine company is named as YS Biopharma.
- 02 Dec 2016 New trial record